Fresenius Medical Care AG (ETR:FME – Get Free Report)’s stock price crossed below its two hundred day moving average during trading on Wednesday. The stock has a two hundred day moving average of €39.59 and traded as low as €38.02. Fresenius Medical Care shares last traded at €39.04, with a volume of 2,238,388 shares changing hands.
Fresenius Medical Care Price Performance
The stock has a market capitalization of $12.51 billion, a PE ratio of 14.12, a price-to-earnings-growth ratio of 0.42 and a beta of 0.94. The business’s 50-day moving average price is €39.43 and its 200 day moving average price is €39.64. The company has a debt-to-equity ratio of 85.10, a quick ratio of 0.80 and a current ratio of 0.99.
About Fresenius Medical Care
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
Featured Articles
- Five stocks we like better than Fresenius Medical Care
- Q3 Earnings Have Investors Wondering: Is Mercado Libre Finally a Buy?
- CVS Raised Its Outlook and Announced a Breakup—So Why Did the Stock Drop?
- Array and Shoals Are Merging: Who Really Wins the All-Stock Solar Deal?
- Duolingo’s User Growth Is Outpacing Bookings, But Is Its Strategy Paying Off?
Receive News & Ratings for Fresenius Medical Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care and related companies with MarketBeat.com's FREE daily email newsletter.
